The effect of anti-CD44 monoclonal antibodies on differentiation and proliferation of human acute myeloid leukemia cells (Q35888664)

10 August 2017

1 reference

title

The effect of anti-CD44 monoclonal antibodies on differentiation and proliferation of human acute myeloid leukemia cells (English)

1 reference

ORCID Public Data File 2021

10 August 2017

main subject

acute myeloid leukemia

1 reference

1 reference

Christine Chomienne

1 reference

author name string

Zeineb Gadhoum

1 reference

10 August 2017

Jacques Delaunay

1 reference

10 August 2017

Eliane Maquarre

1 reference

10 August 2017

Laetitia Durand

1 reference

10 August 2017

Valérie Lancereaux

1 reference

10 August 2017

Junyuang Qi

1 reference

10 August 2017

Jacqueline Robert-Lezenes

1 reference

10 August 2017

Florence Smadja-Joffe

1 reference

10 August 2017

language of work or name

1 reference

1 August 2004

1 reference

10 August 2017

1 reference

10 August 2017

1 reference

10 August 2017

1 reference

10 August 2017

page(s)

1501-1510

1 reference

Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000206687

CD44 isoforms during differentiation and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000206687

Expression and modulation of CD44 variant isoforms in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000206687

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000206687

Identification of hyaluronic acid binding sites in the extracellular domain of CD44

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000206687

Hyaluronic acid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000206687

The importance of cellular environment to function of the CD44 matrix receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000206687

CD44 and hyaluronan binding by human myeloid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000206687

CD44: from adhesion molecules to signalling regulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000206687

A splice variant of CD44 expressed in the apical ectodermal ridge presents fibroblast growth factors to limb mesenchyme and is required for limb outgrowth

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000206687

Signal transduction via CD44: role of plasma membrane microdomains

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000206687

Identification and functional analysis of the ezrin-binding site in the hyaluronan receptor, CD44.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000206687

The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000206687

CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000206687

CD44 is required for two consecutive steps in HGF/c-Met signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000206687

Engineered mutants of HGF/SF with reduced binding to heparan sulphate proteoglycans, decreased clearance and enhanced activity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000206687

Interaction between the Adhesion Receptor, CD44, and the Oncogene Product, p185 , Promotes Human Ovarian Tumor Cell Activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000206687

CD44 enhances neuregulin signaling by Schwann cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000206687

Signaling through CD44 is mediated by tyrosine kinases. Association with p56lck in T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000206687

Evidence of involvement of CD44 in endothelial cell proliferation, migration and angiogenesis in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000206687

CD44: a new means to inhibit acute myeloid leukemia cell proliferation via p27Kip1

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000206687

Monoclonal antibodies to Pgp-1/CD44 block lympho-hemopoiesis in long-term bone marrow cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000206687

Two different functions for CD44 proteins in human myelopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000206687

CD44 isoforms in normal and leukemic hematopoiesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000206687

Tissue- and epitope-specific mechanisms account for the diverse effects of anti-CD44 antibodies on the maintenance of primitive hematopoietic progenitors in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000206687

Presenilin-dependent intramembrane proteolysis of CD44 leads to the liberation of its intracellular domain and the secretion of an Abeta-like peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000206687

21 January 2018

The liberation of CD44.

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000206687

Haemopoiesis in long-term bone marrow cultures. A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000206687

Identification of the haematopoietic stem cell niche and control of the niche size

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000206687

CD44 in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000206687

Induction of resistance to diabetes in non-obese diabetic mice by targeting CD44 with a specific monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000206687

Tumor targeting properties of monoclonal antibodies with different affinity for target antigen CD44V6 in nude mice bearing head-and-neck cancer xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000206687

CD44s-targeted treatment with monoclonal antibody blocks intracerebral invasion and growth of 9L gliosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000206687

Antibodies to CD44 and integrin alpha4, but not L-selectin, prevent central nervous system inflammation and experimental encephalomyelitis by blocking secondary leukocyte recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000206687

Retardation of metastatic tumor growth after immunization with metastasis-specific monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000206687

Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000206687

A cell initiating human acute myeloid leukaemia after transplantation into SCID mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000206687

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000206687

Unique molecular and cellular features of acute myelogenous leukemia stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000206687

Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000206687

MAD1 and p27(KIP1) cooperate to promote terminal differentiation of granulocytes and to inhibit Myc expression and cyclin E-CDK2 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000206687

Decorin inhibits macrophage colony-stimulating factor proliferation of macrophages and enhances cell survival through induction of p27(Kip1) and p21(Waf1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000206687

Stem cell repopulation efficiency but not pool size is governed by p27(kip1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000206687

A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000206687

Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000206687

Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000206687

Prognostic significance of the cell cycle inhibitor p27Kip1 in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000206687

Interleukin-7 promotes survival and cell cycle progression of T-cell acute lymphoblastic leukemia cells by down-regulating the cyclin-dependent kinase inhibitor p27(kip1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000206687

Arsenic trioxide, a therapeutic agent for APL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000206687

Combined effect of all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000206687

Differentiation therapy in acute myelogenous leukemia (non-APL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000206687

Novel therapeutics for chemotherapy-resistant acute myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000206687

Progress in the treatment of acute myeloid leukaemia in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000206687

Targeted therapies for the myeloid leukaemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000206687

Antibody-based treatment of acute myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000206687

10.1080/1042819042000206687

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference